(WASHINGTON)Generic drug maker Barr Pharmaceuticals Inc. spent over $1.5 million lobbying on legislation affecting the drug industry in the second quarter, according to a recent disclosure for...READ MORE

(NEW YORK)Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing ...READ MORE

(MONTVALE, N.J.)Generic drug maker Barr Pharmaceuticals says its second-quarter earnings rose 27 percent on higher product sales. New Jersey-based Barr says profit rose to $57 million, or 52 cents...READ MORE

(PITTSBURGH)Generic drug maker Mylan Inc. said Wednesday it has entered a partnership to develop and sell 22 oral contraceptives in the U.S., which it hopes to begin marketing in 2010.READ MORE

Among the earnings stories for Tuesday, July 29, from AP Financial News: NEW YORK (AP)_ Teva Pharmaceutical Industries Ltd. said Tuesday its second-quarter profit rose 4.6 percent ...READ MORE

(NEW YORK)Teva Pharmaceutical Industries Ltd. said Tuesday its second-quarter profit rose 4.6 percent on a steady increase worldwide in generic drug sales and its branded multiple sclerosis ...READ MORE

(NEW YORK)Teva Pharmaceutical Industries Ltd. said Tuesday its board of directors declared a quarterly dividend of about 13 cents per share. Israel-based Teva said the dividend value is base...READ MORE